Younok Dumortier Shin
Keine laufenden Positionen mehr
Profil
Younok Dumortier Shin served as Vice President & Managing Director at Dermelix Biotherapeutics, LLC.
She was also the Chief Technology Officer at Avalo Therapeutics, Inc. from 2020 to 2022.
She holds a graduate and doctorate degree from McGill University, an MBA from Babson College, and an undergraduate degree from the University of British Columbia.
Ehemalige bekannte Positionen von Younok Dumortier Shin
Unternehmen | Position | Ende |
---|---|---|
AVALO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
Dermelix Biotherapeutics, Llc
Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Corporate Officer/Principal | - |
Ausbildung von Younok Dumortier Shin
University of British Columbia | Undergraduate Degree |
McGill University | Doctorate Degree |
Babson College | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Dermelix Biotherapeutics, Llc
Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Commercial Services |